Axeda Systems Inc. (Nasdaq: XEDA), the pioneer of the growing market for device relationship management (DRM) enterprise software and services, announced today that Applied Biosystems Group (NYSE:ABI), an Applera Corporation business and a provider of DNA analyzers to the world's top researchers including the Human Genome Project, will utilize the Axeda Device Relationship Management System™ in its new ABI PRISM® 3730/3730xl DNA Analyzers. Applied Biosystems will now be able to access the operational parameters within each device remotely, enabling the remote diagnostics, preventative maintenance, failure prediction, and proactive notification that will decrease the downtime of these data-rich, high-speed DNA analyzers.
"The Axeda DRM system allows the Applied Biosystems service team to identify lasers that are nearing the end of their life and operational issues such as changes in electrophoresis current that could cause a customer to lose samples and data. The engineers can then diagnose and fix the problem and in some cases complete the work remotely," said Patrick Carroll, Applied Biosystems Vice President for Worldwide Sales and Service. "Data accuracy is the top priority of our DNA analyzer customers. Issues during data collection can cause degradation of the quality of analysis, which previously would not be detected until the run is complete, and can cause the loss of valuable samples."
"Loss of productivity due to equipment downtime is very expensive, and the state-of-the-art technology used by Applied Biosystems requires sophisticated field service and support," said Robert M. Russell Jr., chairman and CEO of Axeda Systems Inc. "Using the continuous monitoring, remote access, and automated device data management capabilities of Axeda DRM will maximize instrument uptime, minimize service response time, and result in a significant savings for Applied Biosystems and it's customers."
The Axeda Device Relationship Management System is a powerful and practical enterprise software solution for remote device information management. With Axeda DRM™, organizations can now leverage the Internet to monitor, manage, and service intelligent devices deployed at remote sites anywhere in the world-cost effectively and in real time. These companies rapidly gain competitive advantage by increasing their operating efficiency and profitability while simultaneously improving customer satisfaction and retention.
ABI PRISM® 3730/3730xl DNA Analyzers represent the next generation of high-throughput sequencing and fragment analysis platforms. They combine reliability, high data quality, and production capacity to provide the ideal platform for rapid, accurate, cost-effective DNA analysis. Designed and built by the same team that introduced the ABI PRISM® 3100 Genetic Analyzer, the 48-capillary ABI PRISM® 3730 DNA Analyzer and the 96-capillary ABI PRISM®3730/xl Analyzer combine new advances in automation and optics with Applied Biosystems proprietary reagents and software to meet the production needs of higher throughput researchers and core facilities.
Axeda Systems Inc. (NASDAQ: XEDA) is the pioneer in the growing market for device relationship management (DRM) enterprise software and services. Axeda helps businesses become more competitive by using the Internet to extract real time information hidden in their intelligent devices. The company's flagship product, the Axeda Device Relationship Management System is a distributed software solution that lets businesses remotely monitor, manage and service intelligent devices, deployed around the world, allowing them to optimize their service, development, sales and manufacturing operations. Axeda customers are Global 2000 companies in many markets including Industrial and Building Automation, High-technology, Medical Instrumentation, Office Automation and Semiconductor Equipment industries. Axeda has sales and service offices in the US, Europe and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com .
Applera Corporation comprises two operating groups. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries leading to the development of new pharmaceuticals, and to conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.6 billion during fiscal 2002. The Celera Genomics Group (NYSE:CRA), located in Rockville, MD and South San Francisco, CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its genomics and proteomics technology platforms to identify drug targets and diagnostic marker candidates, and to discover novel therapeutics. Its Celera Discovery System™ online platform, to be marketed exclusively through the Knowledge Business of Applied Biosystems, is an integrated source of information based on the human genome and other biological and medical sources. Celera Diagnostics, a joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostics tests. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at http://www.applera.com/ or by telephoning 800.762.6923. Information about Applied Biosystems is available on the World Wide Web at http://www.appliedbiosystems.com .
Everyday intelligent devices such as copiers, elevators, vending machines, building control units, medical devices, and even automobiles are an important new source of business information. device relationship management is a growing new market that allows companies to tap into this valuable information anytime anywhere. Pioneered by Axeda, device relationship management technology provides a distributed information management system that leverages the Internet to allow timely, accurate, and unbiased information to be communicated automatically between intelligent devices, wherever they are deployed around the world, and service personnel or enterprise business systems. Device Relationship Management helps turn reactive businesses into proactive businesses providing new sources of revenue, increased operational efficiency and lower costs with an ROI that is often measured in months.
Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com
